Titre : Composés benzhydryliques

Composés benzhydryliques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Robotics
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Composés benzhydryliques : Questions médicales les plus fréquentes", "headline": "Composés benzhydryliques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Composés benzhydryliques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-14", "dateModified": "2025-03-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Composés benzhydryliques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dérivés du benzène", "url": "https://questionsmedicales.fr/mesh/D001555", "about": { "@type": "MedicalCondition", "name": "Dérivés du benzène", "code": { "@type": "MedicalCode", "code": "D001555", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Diphénhydramine", "alternateName": "Diphenhydramine", "url": "https://questionsmedicales.fr/mesh/D004155", "about": { "@type": "MedicalCondition", "name": "Diphénhydramine", "code": { "@type": "MedicalCode", "code": "D004155", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.115.250" } } }, { "@type": "MedicalWebPage", "name": "2,2'-Dichloro-4,4'-méthylènedianiline", "alternateName": "Methylenebis(chloroaniline)", "url": "https://questionsmedicales.fr/mesh/D008753", "about": { "@type": "MedicalCondition", "name": "2,2'-Dichloro-4,4'-méthylènedianiline", "code": { "@type": "MedicalCode", "code": "D008753", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.115.500" } } }, { "@type": "MedicalWebPage", "name": "Modafinil", "alternateName": "Modafinil", "url": "https://questionsmedicales.fr/mesh/D000077408", "about": { "@type": "MedicalCondition", "name": "Modafinil", "code": { "@type": "MedicalCode", "code": "D000077408", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.115.550" } } }, { "@type": "MedicalWebPage", "name": "Orphénadrine", "alternateName": "Orphenadrine", "url": "https://questionsmedicales.fr/mesh/D009966", "about": { "@type": "MedicalCondition", "name": "Orphénadrine", "code": { "@type": "MedicalCode", "code": "D009966", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.115.600" } } } ], "about": { "@type": "MedicalCondition", "name": "Composés benzhydryliques", "alternateName": "Benzhydryl Compounds", "code": { "@type": "MedicalCode", "code": "D001559", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Loyd V Allen", "url": "https://questionsmedicales.fr/author/Loyd%20V%20Allen", "affiliation": { "@type": "Organization", "name": "International Journal of Pharmaceutical Compounding. lallen@ijpc.com." } }, { "@type": "Person", "name": "Jonas Bresien", "url": "https://questionsmedicales.fr/author/Jonas%20Bresien", "affiliation": { "@type": "Organization", "name": "Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany. axel.schulz@uni-rostock.de." } }, { "@type": "Person", "name": "Jose M Goicoechea", "url": "https://questionsmedicales.fr/author/Jose%20M%20Goicoechea", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Alexander Hinz", "url": "https://questionsmedicales.fr/author/Alexander%20Hinz", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Moritz T Scharnhölz", "url": "https://questionsmedicales.fr/author/Moritz%20T%20Scharnh%C3%B6lz", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Initial Experience of Single-Port Robotic Lobectomy for Large-Sized Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.", "datePublished": "2024-09-05", "url": "https://questionsmedicales.fr/article/39272949", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cancers16173091" } }, { "@type": "ScholarlyArticle", "name": "A novel pelvis-prostate model BPPP predicts immediate urinary continence after Retzius-sparing robotic-assisted laparoscopic radical prostatectomy.", "datePublished": "2024-08-20", "url": "https://questionsmedicales.fr/article/39164347", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-70080-8" } }, { "@type": "ScholarlyArticle", "name": "Features related to temporary tracheotomy in patients undergoing Transoral Robotic Surgery (TORS) for supraglottic squamous cell cancer of the larynx: A systematic review.", "datePublished": "2024-07-25", "url": "https://questionsmedicales.fr/article/39068815", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.amjoto.2024.104436" } }, { "@type": "ScholarlyArticle", "name": "Win ratio analysis of short-term clinical outcomes of focal therapy and robot-assisted radical prostatectomy for the patients with localized prostate cancer.", "datePublished": "2024-07-24", "url": "https://questionsmedicales.fr/article/39043819", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-67592-8" } }, { "@type": "ScholarlyArticle", "name": "Postoperative Complications and Readmission Rates in Robotic-Assisted Versus Manual Total Knee Arthroplasty: Large, Propensity Score-Matched Patient Cohorts.", "datePublished": "2024-07-19", "url": "https://questionsmedicales.fr/article/39029449", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5435/JAAOS-D-23-01117" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Composés benzhydryliques", "item": "https://questionsmedicales.fr/mesh/D001559" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Composés benzhydryliques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Composés benzhydryliques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Composés benzhydryliques", "description": "Comment diagnostiquer une intoxication aux composés benzhydryliques ?\nQuels tests sont utilisés pour évaluer l'exposition ?\nQuels symptômes indiquent une surdose ?\nComment différencier les effets des composés benzhydryliques ?\nQuels signes cliniques sont associés à ces composés ?", "url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Robotics&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Composés benzhydryliques", "description": "Quels sont les symptômes courants d'une exposition ?\nPeut-on avoir des réactions cutanées ?\nQuels effets neurologiques peuvent se manifester ?\nY a-t-il des symptômes respiratoires associés ?\nLes symptômes varient-ils selon la dose ?", "url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Robotics&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Composés benzhydryliques", "description": "Comment prévenir l'exposition aux composés benzhydryliques ?\nY a-t-il des formations recommandées ?\nQuels sont les conseils de stockage sécuritaire ?\nComment sensibiliser le personnel aux risques ?\nQuelles sont les réglementations à suivre ?", "url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Robotics&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Composés benzhydryliques", "description": "Quel est le traitement principal en cas d'intoxication ?\nDes antidotes spécifiques existent-ils ?\nComment gérer les symptômes neurologiques ?\nQuelle est l'importance de l'hydratation ?\nQuand faut-il envisager une hospitalisation ?", "url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Robotics&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Composés benzhydryliques", "description": "Quelles complications peuvent survenir après une exposition ?\nLes effets à long terme sont-ils possibles ?\nComment les complications sont-elles gérées ?\nY a-t-il des risques de cancer associés ?\nLes complications peuvent-elles être évitées ?", "url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Robotics&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Composés benzhydryliques", "description": "Quels sont les principaux facteurs de risque d'exposition ?\nL'âge influence-t-il le risque d'effets ?\nLes antécédents médicaux jouent-ils un rôle ?\nLes conditions environnementales affectent-elles le risque ?\nLes habitudes de vie influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Robotics&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux composés benzhydryliques ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique médical et des tests de laboratoire spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'exposition ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses sanguines et urinaires peuvent détecter la présence de ces composés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une surdose ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent confusion, somnolence et troubles respiratoires." } }, { "@type": "Question", "name": "Comment différencier les effets des composés benzhydryliques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation clinique complète et l'historique des médicaments sont nécessaires." } }, { "@type": "Question", "name": "Quels signes cliniques sont associés à ces composés ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des anomalies neurologiques et des troubles cardiovasculaires." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une exposition ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vertiges et des maux de tête." } }, { "@type": "Question", "name": "Peut-on avoir des réactions cutanées ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des éruptions cutanées et des démangeaisons peuvent survenir." } }, { "@type": "Question", "name": "Quels effets neurologiques peuvent se manifester ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de la coordination et des convulsions peuvent se produire." } }, { "@type": "Question", "name": "Y a-t-il des symptômes respiratoires associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des difficultés respiratoires et une respiration rapide peuvent apparaître." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la dose ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux composés benzhydryliques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection lors de la manipulation de ces substances." } }, { "@type": "Question", "name": "Y a-t-il des formations recommandées ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des formations sur la manipulation sécurisée des produits chimiques sont conseillées." } }, { "@type": "Question", "name": "Quels sont les conseils de stockage sécuritaire ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Stocker dans des contenants étiquetés et dans des zones bien ventilées." } }, { "@type": "Question", "name": "Comment sensibiliser le personnel aux risques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Organiser des sessions d'information régulières sur les dangers des composés." } }, { "@type": "Question", "name": "Quelles sont les réglementations à suivre ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Respecter les réglementations locales et nationales sur la manipulation des produits chimiques." } }, { "@type": "Question", "name": "Quel est le traitement principal en cas d'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement comprend l'administration de charbon actif et une surveillance médicale." } }, { "@type": "Question", "name": "Des antidotes spécifiques existent-ils ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique pour les composés benzhydryliques." } }, { "@type": "Question", "name": "Comment gérer les symptômes neurologiques ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments anticonvulsivants peuvent être administrés pour contrôler les crises." } }, { "@type": "Question", "name": "Quelle est l'importance de l'hydratation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'hydratation est cruciale pour aider à éliminer les toxines du corps." } }, { "@type": "Question", "name": "Quand faut-il envisager une hospitalisation ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'hospitalisation est nécessaire en cas de symptômes graves ou de complications." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une exposition ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques et respiratoires peuvent se développer." } }, { "@type": "Question", "name": "Les effets à long terme sont-ils possibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets à long terme sur la santé peuvent survenir après une exposition prolongée." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite un suivi médical régulier et des traitements adaptés." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer associés ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien potentiel entre l'exposition et le cancer." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en respectant les mesures de sécurité et en évitant l'exposition." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'exposition ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs en laboratoire et ceux manipulant des produits chimiques sont à risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'effets ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants et les personnes âgées sont plus vulnérables." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies respiratoires augmentent le risque." } }, { "@type": "Question", "name": "Les conditions environnementales affectent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition dans des environnements mal ventilés augmente le risque." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme et l'alcoolisme peuvent exacerber les effets des composés." } } ] } ] }

Sources (10000 au total)

Features related to temporary tracheotomy in patients undergoing Transoral Robotic Surgery (TORS) for supraglottic squamous cell cancer of the larynx: A systematic review.

The aim of this systematic review is to assess a relation between demographical, clinical and tumoral features and the need for a prophylactic tracheotomy during TORS procedure in patients affected by... PRISMA 2020 guidelines were applied in this systematic literature review. A computerized search was performed using the Embase/Pubmed, Scopus and Cochrane database, for articles published from 2007 to... Through a study selection process 8 full texts were eligible for statistical univariate analysis. The most relevant factor related to a prophylactic tracheotomy was a contextual bilateral cervical nod... The prophylactic tracheotomy is considered a temporary protection strategy to achieve a valid recovery after TORS procedure. However, there are no guidelines regarding its routinely use. Only 25 % of ...

Win ratio analysis of short-term clinical outcomes of focal therapy and robot-assisted radical prostatectomy for the patients with localized prostate cancer.

We compared the comprehensive clinical outcomes of focal therapy (FT) and robot-assisted radical prostatectomy (RARP) in patients with localized prostate cancer (PC) using a win ratio analysis. After ...

Postoperative Complications and Readmission Rates in Robotic-Assisted Versus Manual Total Knee Arthroplasty: Large, Propensity Score-Matched Patient Cohorts.

There is a paucity of research comparing postoperative complication rates between manual total knee arthroplasty (M-TKA) and robotic-assisted total knee arthroplasty (RA-TKA). This study aims to compa... A retrospective review of a multihospital database identified patients who underwent TKA between January 2016 and May 2023. Surgeons who used the robotic-assisted surgery technique in <10% or >90% of ... All-cause 90-day readmission rates were 2.4% for RA-TKA and 2.6% for M-TKA (P = 0.36). RA-TKA had fewer revisits (RA-TKA: 7.8%; M-TKA: 8.8%, P = 0.027) and rates of readmission with >23 hours of obser... In this retrospective matched cohort analysis, RA-TKA was associated with markedly fewer revisits and readmissions with >23 hours of observation compared with M-TKA. No differences in all-cause 90-day... Level III.... Retrospective review....

Implementation and Validation of a High-Fidelity Simulation Model for Surgical Resident Training: Management of Acute Intraoperative Hemorrhage during Robot-assisted Surgery.

To improve our previous simulation-based training module by using sustainable material to mold an anatomically accurate terrain and reproducing major vascular injuries encountered during robot-assiste... The simulator was built with a pump, gauge, and valve linked via silicone tubing. Artificial blood was made from cornstarch, water, and red dye, and pumped through 3D-Med artificial vessels with the d... The apparatus demonstrated high reproducibility across all simulation scenarios, enhancing resident problem-solving skills. Residents' pre-simulation surveys revealed significant concern regarding the... The management of acute hemorrhage during robot-assisted surgery remains a space for additional surgical education and training. Our simulation successfully provided a reliable, reproducible training ...

Liver respiratory-induced motion estimation using abdominal surface displacement as a surrogate: robotic phantom and clinical validation with varied correspondence models.

This work presents the implementation of an RGB-D camera as a surrogate signal for liver respiratory-induced motion estimation. This study aims to validate the feasibility of RGB-D cameras as a surrog... The proposed approach uses an RGB-D camera to compute an abdominal surface reconstruction and estimate the liver respiratory-induced motion. Two sets of validation experiments were conducted, first, u... The motion model for the robotic liver phantom displayed an error below 3 mm with a coefficient of determination above 90% for the different directions of motion. The clinical study presented errors o... RGB-D cameras are a promising method to accurately estimate the liver respiratory-induced motion. The internal motion can be estimated in a non-contact, noninvasive and flexible approach. Additionally...

Is it safe to defer prostate cancer treatment? Assessing the impact of surgical delay on the risk of pathological upstaging after robot-assisted radical prostatectomy.

We sought to investigate whether surgical delay may be associated with pathological upstaging in patients treated with robot assisted radical prostatectomy (RARP) for localized and locally advanced pr... Consecutive firstly-diagnosed PCa patients starting from March 2020 have been enrolled. All the patients were categorized according to EAU risk categories for PCa risk. Uni- and multivariate analysis ... Overall 2017 patients entered the study. Median age at surgery was 68 (IQR 63-73) years. Overall low risk, intermediate risk, localized high risk and locally advanced disease were recorded in 368 (18.... In localized high-risk disease surgical delay could be associated with a higher risk of adverse pathologic findings....

Safety and oncological outcome of early intraoperative intravesicle mitomycin C vs. deferred instillation in patients receiving robot-assisted radical nephroureterectomy.

Radical nephroureterectomy with concurrent bladder cuff excision (RNUBCE) is the gold standard surgical approach for high-risk primary upper tract urothelial carcinoma (UTUC). Given the notably high i... This is a retrospective chart review study. Patients with non-invasive (N0, not T3/T4) UTUC who underwent robotic RNUBCE combined an intraoperative MMC instillation or a deferred MMC instillation afte... A total of 54 patients were included in the analysis. 12 (22.2%) patients experienced a bladder tumor recurrence during follow-up (IO: 7.7%, PO: 35.7%,... IIntraoperative MMC instillation is safe and associated with a lower bladder tumor recurrence risk in patients undergoing robotic RNUBCE for UTUC than deferred instillation. Future large, prospective ...